C Vivancos Sánchez1, A Palpán Flores2, V Rodríguez Domínguez2, A Zamarrón Pérez2, C Álvarez-Escolá3, C Pérez López2. 1. Neurosurgery Department, Hospital Universitario La Paz, Paseo de la Castellana, 261, Madrid, 28046, Spain. catalina.vivancos@gmail.com. 2. Neurosurgery Department, Hospital Universitario La Paz, Paseo de la Castellana, 261, Madrid, 28046, Spain. 3. Endocrinology Department, Hospital Universitario La Paz, Paseo de la Castellana, 261, Madrid, 28046, Spain.
Abstract
PURPOSE: To investigate endocrine function changes after non-functioning pituitary adenomas (NFPA) transsphenoidal surgery and to search for predictors of hypopituitarism resolution and development. METHODS: We included 117 patients with NFPA who underwent endoscopic transsphenoidal surgery from 2005 to 2019 by two neurosurgeons. Twenty-one patients were excluded because of previous pituitary surgery or radiotherapy. We assessed symptoms at diagnosis, tumour volume, tumour removal, hormonal status at diagnosis, hormonal outcomes at 2- and 12-month follow-up, and complications. Pituitary stalk and gland MRI status (visible or not) were included, and it theirs association to hormonal function was studied for the first time, to our knowledge. RESULTS: Pituitary gland visualization was more frequent in those patients who showed a smaller number of axes affected at 12 months (p = 0.011). Pituitary stalk status showed no association to hormonal function. The hormonal normalization rate at 12 months was 13%. The endocrine improvement rate at 12 months was 16.7%. Worsening of hormonal function occurred in 19.8% of patients. Younger age was associated to hormonal improvement (p = 0.004). Higher preoperative tumour volume (p = 0.015) and absence of gross total resection (GTR) (p = 0.049) were associated with worsening in at least one hormonal axis after surgery. CONCLUSIONS: Pituitary gland visibility was higher in those patients who showed better hormonal outcomes. Assessment of initial hormonal function and outcome after surgery regarding pituitary stalk status showed no significant association. Higher preoperative tumour volumes and absence of GTR were associated to postoperative endocrine function worsening, while younger age was associated to its improvement.
PURPOSE: To investigate endocrine function changes after non-functioning pituitary adenomas (NFPA) transsphenoidal surgery and to search for predictors of hypopituitarism resolution and development. METHODS: We included 117 patients with NFPA who underwent endoscopic transsphenoidal surgery from 2005 to 2019 by two neurosurgeons. Twenty-one patients were excluded because of previous pituitary surgery or radiotherapy. We assessed symptoms at diagnosis, tumour volume, tumour removal, hormonal status at diagnosis, hormonal outcomes at 2- and 12-month follow-up, and complications. Pituitary stalk and gland MRI status (visible or not) were included, and it theirs association to hormonal function was studied for the first time, to our knowledge. RESULTS: Pituitary gland visualization was more frequent in those patients who showed a smaller number of axes affected at 12 months (p = 0.011). Pituitary stalk status showed no association to hormonal function. The hormonal normalization rate at 12 months was 13%. The endocrine improvement rate at 12 months was 16.7%. Worsening of hormonal function occurred in 19.8% of patients. Younger age was associated to hormonal improvement (p = 0.004). Higher preoperative tumour volume (p = 0.015) and absence of gross total resection (GTR) (p = 0.049) were associated with worsening in at least one hormonal axis after surgery. CONCLUSIONS: Pituitary gland visibility was higher in those patients who showed better hormonal outcomes. Assessment of initial hormonal function and outcome after surgery regarding pituitary stalk status showed no significant association. Higher preoperative tumour volumes and absence of GTR were associated to postoperative endocrine function worsening, while younger age was associated to its improvement.
Authors: Maria Fleseriu; Mary E Bodach; Luis M Tumialan; Vivien Bonert; Nelson M Oyesiku; Chirag G Patil; Zachary Litvack; Manish K Aghi; Gabriel Zada Journal: Neurosurgery Date: 2016-10 Impact factor: 4.654
Authors: Won Hyung A Ryu; Samantha Tam; Brian Rotenberg; Mohamed Ahmed Labib; Donald Lee; David A Nicolle; Stan Van Uum; Neil Duggal Journal: Can J Neurol Sci Date: 2010-11 Impact factor: 2.104
Authors: M Mercè Fernández-Balsells; Mohammad Hassan Murad; Amelia Barwise; Juan F Gallegos-Orozco; Anu Paul; Melanie A Lane; Julianna F Lampropulos; Inés Natividad; Lilisbeth Perestelo-Pérez; Paula G Ponce de León-Lovatón; Patricia J Erwin; Jantey Carey; Victor M Montori Journal: J Clin Endocrinol Metab Date: 2011-04 Impact factor: 5.958
Authors: Arman Jahangiri; Jeffrey R Wagner; Sung Won Han; Mai T Tran; Liane M Miller; Rebecca Chen; Maxwell W Tom; Lauren R Ostling; Sandeep Kunwar; Lewis Blevins; Manish K Aghi Journal: J Neurosurg Date: 2015-08-07 Impact factor: 5.115
Authors: O M Dekkers; S Hammer; R J W de Keizer; F Roelfsema; P J Schutte; J W A Smit; J A Romijn; A M Pereira Journal: Eur J Endocrinol Date: 2007-02 Impact factor: 6.664
Authors: Pamela U Freda; Albert M Beckers; Laurence Katznelson; Mark E Molitch; Victor M Montori; Kalmon D Post; Mary Lee Vance Journal: J Clin Endocrinol Metab Date: 2011-04 Impact factor: 5.958